# Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of <i>HER2</i>-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lapatinib-plus-paclitaxel-versus-paclitaxel-alone-in-the-second-line-treatment/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Taroh Satoh,Rui‐Hua Xu,Hyun Cheol Chung,Guoping Sun,Toshihiko Doi,Jianming Xu,Akihito Tsuji,Yasushi Omuro,Jin Li,Jinwan Wang,Hiroto Miwa,Shukui Qin,Ik‐Joo Chung,Kun‐Huei Yeh,Jifeng Feng,Akihira Mukaiyama,Mikiro Kobayashi,Atsushi Ohtsu,Yung‐Jue Bang |
| Citations | 627 |
| DOI | 10.1200/jco.2013.53.6136 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://ir.ymlib.yonsei.ac.kr/handle/22282913/99403 |
| OpenAlex ID | https://openalex.org/W2008322008 |
| PMID | 24868024 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Hiroto Miwa](https://scholariq.org/researchers/hiroto-miwa/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

## Paper topics

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.